Trial Profile
A Phase II, randomized, active and vehicle controlled, Investigator blind, multi-centre study to evaluate the efficacy, safety and tolerability of topically applied tretinoin formulated with TPM as an anti-acne preparation in human subjects with acne vulgaris.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Jun 2016
Price :
$35
*
At a glance
- Drugs Tretinoin (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors Phosphagenics
- 19 Nov 2014 New source identified and integrated: Australian New Zealand Clinical Trials Registry record.
- 08 Oct 2014 Status changed from active, no longer recruiting to completed, according to a Phosphagenics media release.
- 07 Oct 2014 Primary endpoints (change in total acne lesion count, and success rate on the Investigators Global Assessment) have not been met, but the trial was not powered for significance, according to a Phosphagenics media release.